Rabies Veterinary Vaccines Market Size Worth $890.46 Million By 2032 | CAGR: 4.2%

Rabies Veterinary Vaccines Market Size Worth $890.46 Million By 2032 | CAGR: 4.2%

The global rabies veterinary vaccines market size is expected to reach USD 890.46 million by 2032, according to a new study by Polaris Market Research. The report “Rabies Veterinary Vaccines Market Share, Size, Trends, Industry Analysis Report, By Application (Companion Animals, Livestock Animals, Wildlife Animals); By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.


The rising prevalence of rabies all over the world is expected to become a major driving force for the market over the forecast period, increasing no of infections from animals resulting in human mortality helps in the growth of the market.  Adoption is higher in North America as compared to other nations. This is because of the large pet population, & expensive veterinary healthcare expenditures. Additionally, the high annual public health expenditures in these regions to eradicate rabies virus helps in the growth of the market.


According to the Centers for Disease Control and Prevention (CDC), within 28 days of the first vaccine. If the original vaccine was given at least 28 days ago or booster vaccinations were given in line with instructions, an animal is considered presently vaccinated and immunized. Because a quick anamnestic reaction is predicted, an animal is deemed presently immunized immediately following booster immunization.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/rabies-veterinary-vaccines-market/request-for-sample


As per WHO, rabies veterinary vaccines may be divided into several vaccines based on whether they are live or inactivated and depending on the properties of the cell substrate that is utilized for viral replication. According to vaccination properties, these vaccines are manufactured for delivery to domestic animals or wild species via parenteral or oral methods. In both Europe and the USA, oral rabies vaccinations are often administered to foxes and raccoons. In developing countries, trials for oral dog immunization are underway.


As a part of the rabies control strategy, WOAH collaborates with the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), and the Global Alliance for Rabies Control (GARC) to develop on international recommendations aimed to eradicate rabies, by 2030. Rabies Veterinary Vaccines are widely used in pets and livestock animals as the virus can easily affect humans. Some nations have already eliminated rabies through strong preventative measures, while the disease still exists in others, mostly harming wild host animals.


Rabies Veterinary Vaccines Market Report Highlights

  • Companion animals segment is projected to grow at a significant rate over the study period, owing to the increasing percentages of homes owning dogs or cats also strict regulation for animal vaccination boosts the market growth.
  • Wildlife Animal segment sector is expected to hold a significant market share over the forecast period due to the increase in the number of people infected with this virus as a result of encounters with animals will favor market expansion.
  • North America is expected to grow at a considerable CAGR \over the projected period on account of the increasing pet population and high veterinary healthcare costs. Moreover, the use of mass vaccination programs by government organizations in that region increases market growth.
  • The global players include Merck, Indian Immunologicals, Novartis, Pfizer Inc, Sanofi, Boehringer Ingelheim, BroadChem Philippines Biopharma Corporation, Berna Biotech, Elanco, Ceva, Biogénesis Bagó, Bharat Biotech, and GlaxoSmithKline.


Polaris Market Research has segmented the Rabies Veterinary Vaccines market report based on application and region:


Rabies Veterinary Vaccines, Application Outlook (Revenue - USD Million, 2019-2032)

  • Companion Animals
  • Livestock Animals
  • Wildlife Animals

Rabies Veterinary Vaccines, Regional Outlook (Revenue - USD Million, 2019-2032)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa